Rentokil Initial (RTO) Stock Forecast & Price Target
$11.62B
Market Cap
24.60
P/E
21.98
Forward P/E
54
Score
RTO price $23.09 +0.29 +1.29%
Stocklytics score rationale: value 61, quality 50, growth 50.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 2168100000 | 2412300000 | 2472300000 | 2714400000 | 2789400000 | 2953900000 | 3714000000 | 5375000000 | 5436000000 | 6914490613 |
Rentokil Initial plc is a global service provider operating across North America, the United Kingdom, Europe, Asia, and the Pacific, delivering a wide array of essential business support solutions through a route-based model. The company offers comprehensive pest control for both commercial and residential customers, addressing issues ranging from rodents and insects to wildlife management. Its extensive hygiene…
Consensus Buy from 4 analysts. Average price target $26.70, +15.7% versus the current price. Low $26.70. High $26.70.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $26.70 for Rentokil Initial (RTO), 15.5% above the current price of $23.12. Of 4 analysts covering the stock, 3 rate it Buy or Strong Buy, 1 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $26.70 |
|---|---|
| Average | $26.70 |
| High | $26.70 |
The average is 15.5% above the current price of $23.12.
Of 4 analysts, 3 rate Rentokil Initial Buy or Strong Buy, 1 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
Analyst averages on file: 2026, EPS $1.05, revenue $5.43 billion. 2027, EPS $1.14, revenue $5.58 billion.
The Stocklytics Score for RTO is 54 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$26.70 average, with a published range of $26.70 to $26.70.
The consensus is Buy from 4 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $1.05. The average revenue estimate is $5.43 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: Rentokil Initial · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$11.62B
Market Cap
24.60
P/E
21.98
Forward P/E
54
Score